• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 20
  3. 21
  4. 22
  5. 23
  6. 24
  7. …
  • All COVID-19 restrictions to end on 31 January

    Denmark // 26 January, 2022

    COVID-19 no longer classified as “socially critical disease”…

    COVID-19

  • WHO COVID-19 Weekly Reports, January 2022

    25 January, 2022

    Summary of WHO weekly reports...

    COVID-19

  • Pfizer and BioNTech commence trial of Omicron specific vaccine

    25 January, 2022

    Pfizer and BioNTech commence variant specific vaccine trial...

    COVID-19

  • USA Food and Drug Administration revises authorisations for certain COVID-19 treatments

    United States // 25 January, 2022

    US FDA revises monocolonal antibody treatment authorisation...

    COVID-19

  • Vaccine update - Five year olds eligible for Pfizer

    Egypt // 25 January, 2022

    Pfizer vaccine is eligible for five-year-olds

    COVID-19

  • COVID-19 Updates, January 2022 - FDA limits use of some treatment options

    United States // 25 January, 2022

    Omicron now dominant, limited use of some treatment options...

    COVID-19

  • Omicron cases doubling in European Region

    24 January, 2022

    Statement from WHO Regional Director for Europe…

    COVID-19

  • Novavax approved for emergency use

    Belgium // 24 January, 2022

    First doses to arrive in February…

    COVID-19

  • WHO Director General opens the 150th session of the Executive Board

    24 January, 2022

    150th session of WHO Executive Board opening remarks...

    COVID-19

  • Study: Increased antibodies with differing booster vaccines after Sinovac primary schedule

    24 January, 2022

    Booster with different vaccine after Sinovac/CoronaVac is more effective...

    COVID-19

  • Study: COVID-19 may infect the inner ear causing symptoms

    24 January, 2022

    COVID-19 may infect the inner ear leading to pain, hearing loss, tinnitus...

    COVID-19

  • Vaccination for children and fourth booster shots planned

    Thailand // 24 January, 2022

    Vaccintion for children between 5 and 11 years; fourth vaccine dose for residents in...

    COVID-19

  • Omicron sub-lineage BA.2 as variant under investigation (VUI)

    United Kingdom // 22 January, 2022

    UK Health Security Agency (UKHSA) has stated...

    COVID-19

  • Strong antibody response among those infected with COVID-19 post-vaccination, study

    United States // 22 January, 2022

    The more exposure to SARS-CoV-2 antigens, the more enhanced the quality of antibody responses...

    COVID-19

  • CDC studies show booster doses protective against Omicron

    United States // 21 January, 2022

    Two studies from the CDC show that booster doses were protective against...

    COVID-19

  • WHO SAGE meeting from 19 January

    21 January, 2022

    Booster doses recommended…

    COVID-19

  • PAHO statement regarding Omicron wave in the Americas

    21 January, 2022

    Omicron variant driving hospitalisation and illness…

    COVID-19

  • Age for Paxlovid administration lowered; new testing guidelines announced

    South Korea // 21 January, 2022

    Health authorities have lowered (in Korean) the age for Paxlovid administration from 65 to...

    COVID-19

  • Risks for COVID-19 infection and hospitalization following previous infection and vaccination

    21 January, 2022

    Vaccination is protective

    COVID-19

  • ECDC analysis of COVID-19 vaccine effectiveness

    20 January, 2022

    The ECDC released an interim analysis on a multi-country vaccine effectiveness study that is ongoing...

    COVID-19

  1. …
  2. 20
  3. 21
  4. 22
  5. 23
  6. 24
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS